HomeHealthcare & Life SciencesMedical Devices Radiopharmaceutical Synthesizer Market

Asia Pacific Radiopharmaceutical Synthesizer Market Size & Outlook, 2025-2033


Asia Pacific Radiopharmaceutical Synthesizer Market Insights

  • As per Reed Intelligence insights, Asia Pacific’s Radiopharmaceutical Synthesizer Market was valued at USD 905.82 Million in 2024 and is anticipated to expand to USD 1351.65 Million by 2033.
  • From 2026 to 2033, the market is anticipated to expand at a CAGR of 4.53%.
  • Within Modality, PET accounted for the largest market size in 2024.
  • During the forecast period, PET is anticipated to remain the highest-growth segment within the Modality category.

Other Key Findings


  • Asia Pacific held 28.94% share of the global Radiopharmaceutical Synthesizer Market size in 2024.
  • United States is expected to remain the largest contributor to the global market size by 2033.
  • By 2033, Singapore is anticipated to record the highest growth in Asia Pacific, with the market size expected to reach USD 27.98 Million.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 905.82 Million
Market Size In 2033 USD 1351.65 Million
Largest segment PET
Units Revenue in USD Million
CAGR 4.53% (2025-2033)
Segmnetation Covered
Asia Pacific
  1. China
  2. India
  3. Japan
  4. Korea
  5. Taiwan
  6. Australia
  7. Singapore
  8. South East Asia
Modality
  1. PET
  2. SPECT
  3. Others
Application
  1. Oncology
  2. Cardiology
  3. Neurology
  4. Others
Radioisotope
  1. Fluorine-18
  2. Carbon-11
  3. Gallium-68
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports